Can a drug curb Self-Harm? new trial aims to find out
NCT ID NCT06622239
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether naltrexone, a medication, can help reduce nonsuicidal self-injury (like cutting or hitting oneself) in people aged 16 and older. About 150 participants will receive either naltrexone or a placebo, and researchers will track how often self-harm occurs. The goal is to see if the drug can lower these behaviors when standard psychiatric treatment hasn't worked.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONSUICIDAL SELF-INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul National University Hospital
Seoul, 03080, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Digital-Plus-In-Person therapy curb teen Self-Injury?
- Can a common drug curb Self-Harm? new trial aims to find out
- Can an online program help teens stop Self-Injury?
- Can a smartphone app help young adults stop self-harming?
- Can an online program help teens stop self-harm? new study tests internet therapy
- Memory aid could unlock hidden mental health history